Bibliographie - 2774 - Stabilis 4.0

Siste oppdatering :
19/11/2024

Referanser 2774

Type :

Journal

Internett-koblingen :

https://doi.org/10.1345/aph.1D335

Forskerteamet :

Westborough - AstraZeneca LP

Forfattere :

McKenzie J.E, Mario Cruz-Rivera M.

Tittel :

Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions.

Nummer :

Ann Pharmacotherapy ; 38: 967-972. 2004

Nivå of Evidence :

fysisk stabilitet :

kjemisk stabilitet :

andre metoder :

Kommentarer :

Lister

Budesonide

Cromoglycate sodium

Ipratropium bromide

Levalbuterol

Salbutamol sulfate

Ingen

23-26°C

Budesonide	Pulmicort® 0.23 mg/ml
Salbutamol sulfate	Proventil® 4.75 mg/ml

0.5

Ingen

23-26°C

Salbutamol sulfate	Proventil® 4.83 mg/ml
Budesonide	Pulmicort® 0.48 mg/ml

0.5

Ingen

23-26°C

Budesonide	Pulmicort® 0.23 mg/mL
Cromoglycate sodium	Intal® 22 mg/mL

0.5

Ingen

23-26°C

Budesonide	Pulmicort® 0.5 mg/mL
Cromoglycate sodium	Intal® 22 mg/mL

0.5

Ingen

23-26°C

Budesonide	Pulmicort® 0.23 mg/mL
Ipratropium bromide	Atrovent® 0.20 mg/mL

0.5

Ingen

23-26°C

Budesonide	Pulmicort® 0.48mg/mL
Ipratropium bromide	Atrovent® 0.20mg/mL

0.5

Ingen

23-26°C

Levalbuterol	Levalbuterol® 0.80mg/mL
Budesonide	Pulmicort® 0.22mg/mL

0.5

Ingen

23-26°C

Budesonide	Pulmicort® 0.22mg/mL
Levalbuterol	Levalbuterol® 1.23mg/mL

0.5

Ingen

23-26°C

Budesonide	Pulmicort® 0.45mg/mL
Levalbuterol	Levalbuterol® 0.74mg/mL

0.5

Mentions Légales